19-50223085-C-T
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 3P and 13B. PM1PP3BP4_StrongBP6BS1BS2
The NM_001145809.2(MYH14):c.565C>T(p.Arg189Cys) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000387 in 1,613,510 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R189H) has been classified as Uncertain significance.
Frequency
Consequence
NM_001145809.2 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant nonsyndromic hearing loss 4AInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- peripheral neuropathy-myopathy-hoarseness-hearing loss syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- nonsyndromic genetic hearing lossInheritance: AD Classification: MODERATE Submitted by: ClinGen
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001145809.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MYH14 | NM_001145809.2 | MANE Select | c.565C>T | p.Arg189Cys | missense splice_region | Exon 4 of 43 | NP_001139281.1 | ||
| MYH14 | NM_001077186.2 | c.565C>T | p.Arg189Cys | missense splice_region | Exon 4 of 42 | NP_001070654.1 | |||
| MYH14 | NM_024729.4 | c.565C>T | p.Arg189Cys | missense splice_region | Exon 4 of 41 | NP_079005.3 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MYH14 | ENST00000642316.2 | MANE Select | c.565C>T | p.Arg189Cys | missense splice_region | Exon 4 of 43 | ENSP00000493594.1 | ||
| MYH14 | ENST00000599920.5 | TSL:1 | c.565C>T | p.Arg189Cys | missense splice_region | Exon 4 of 24 | ENSP00000469573.1 | ||
| MYH14 | ENST00000425460.6 | TSL:5 | c.565C>T | p.Arg189Cys | missense splice_region | Exon 4 of 42 | ENSP00000407879.1 |
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152148Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000638 AC: 159AN: 249262 AF XY: 0.000843 show subpopulations
GnomAD4 exome AF: 0.000396 AC: 579AN: 1461244Hom.: 3 Cov.: 33 AF XY: 0.000528 AC XY: 384AN XY: 726942 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000302 AC: 46AN: 152266Hom.: 1 Cov.: 32 AF XY: 0.000376 AC XY: 28AN XY: 74466 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The Arg189Cys variant in MYH14 has not been previously reported in individuals w ith hearing loss, but has been identified in 0.02% (2/8386) of European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu /EVS/; dbSNP rs200818171). Although this variant has been seen in the general po pulation, its frequency is not high enough to rule out a pathogenic role. Comput ational prediction tools and conservation analyses suggest that the Arg189Cys va riant may impact the protein, though this information is not predictive enough t o determine pathogenicity. In summary, additional information is needed to deter mine the clinical significance of this variant.
Inborn genetic diseases Uncertain:1
The c.565C>T (p.R189C) alteration is located in exon 4 (coding exon 3) of the MYH14 gene. This alteration results from a C to T substitution at nucleotide position 565, causing the arginine (R) at amino acid position 189 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
not provided Benign:1
Autosomal dominant nonsyndromic hearing loss 4A Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at